Gabriel Tinoco, MD

The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States

Disclosure information not submitted.

Presentation(s):

• Paper 84 - A PHASE 2 STUDY OF ROGARATINIB (BAY 1163877) IN SOFT TISSUE SARCOMAS: INITIAL RESULTS IN COHORT OF PATIENTS WITH SUCCINATE DEHYDROGENASE (SDH)-DEFICIENT GASTROINTESTINAL STROMAL TUMOR (GIST)

  Saturday, November 4, 2023
  3:00 PM – 4:00 PM